ARCHIVES

Small Businesses Receive $18 Million From NCI Through SBIR Program

This article is from The Cancer Letter archive.

Vol. 18 No. 31 | July 31, 1992

Download PDF Visit The Full Archive

Related Articles

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

New Methods Uncover 1,800 RNAs Linked To Breast Cancer

December 30, 2011

Report From The Front Lines In War On Cancer Past, Present.

March 3, 2000

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001